## Clinical Presentation & Diagnosis The patient presents with **orthostatic hypotension** (sitting BP 110/70 → standing BP 88/55 mmHg, drop >20 mmHg systolic) and **blunted heart rate response to standing** (HR rises only 4 bpm, normal is ≥10 bpm). This is **drug-induced orthostatic hypotension** caused by the combination of **beta-blocker (atenolol) + nitrate (isosorbide dinitrate)**. ## Mechanism of Orthostatic Hypotension in This Case **Key Point:** Both beta-blockers and nitrates cause vasodilation and/or impaired compensatory tachycardia, leading to orthostatic hypotension. | Drug Class | Mechanism | Contribution | |------------|-----------|---------------| | Beta-blockers (atenolol) | Blunt reflex tachycardia; reduce cardiac output | Prevents HR rise on standing | | Nitrates (isosorbide dinitrate) | Cause venous and arterial vasodilation | Reduce preload and BP | | Combined effect | Synergistic hypotension + blunted compensatory response | **Orthostatic hypotension** | ## Management Strategy **High-Yield:** The management of drug-induced orthostatic hypotension is **dose reduction of the offending agents**, not addition of more drugs. ### Why Reduce Atenolol? - Atenolol is causing **blunted heart rate response** (HR should rise ≥10 bpm on standing; this patient's HR rose only 4 bpm) - The patient's angina is **well-controlled** (only 1–2 episodes/week), so a lower beta-blocker dose is acceptable - Reducing atenolol will restore reflex tachycardia and improve orthostatic tolerance ### Why Introduce Nitrate-Free Interval? - The patient is on isosorbide dinitrate **thrice daily** (likely 10 mg at 8 AM, 1 PM, 6 PM) — this is **continuous dosing with no nitrate-free interval** - Introducing a nitrate-free interval (e.g., give only at 8 AM and 1 PM, omit evening dose) reduces total nitrate load and vasodilatory effect - This prevents both nitrate tolerance and reduces orthostatic hypotension **Clinical Pearl:** A nitrate-free interval of ≥10–12 hours is essential for both preventing tolerance AND reducing side effects like hypotension. ## Why Other Options Are Incorrect **Option 0 (Add amlodipine):** Adding another vasodilator (dihydropyridine CCB) would **worsen orthostatic hypotension**, not improve it. This is a common trap — the problem is too much vasodilation, not too little BP control. The sitting BP (110/70) is acceptable; the problem is the **drop on standing**. **Option 2 (Switch to verapamil):** Verapamil is a **non-dihydropyridine CCB** with negative inotropic and chronotropic effects (similar to beta-blockers). Switching from atenolol to verapamil would **not solve the problem** — verapamil would also blunt reflex tachycardia and cause vasodilation, perpetuating orthostatic hypotension. Additionally, verapamil + nitrate combination can cause severe hypotension. **Option 3 (Urgent coronary angiography):** The patient has **no chest pain** currently and her angina is **well-controlled**. The symptoms (headache, dizziness, syncope) are clearly orthostatic in nature (positional, related to standing), not anginal. There is no indication for urgent angiography. This is a distractor based on the cardiac history. ## Recommended Management 1. **Reduce atenolol:** From 50 mg daily to 25 mg daily (or 37.5 mg daily), reassess in 1–2 weeks 2. **Introduce nitrate-free interval:** Change isosorbide dinitrate from 10 mg TDS to 10 mg BD (e.g., 8 AM and 1 PM), omitting evening dose 3. **Lifestyle measures:** Advise slow positional changes, increased fluid intake, compression stockings if needed 4. **Reassess in 2 weeks:** Confirm resolution of orthostatic symptoms while maintaining anginal control **Mnemonic: ORTHOSTATIC HYPOTENSION = Reduce Offending Drugs** — When a patient on multiple vasodilators/negative inotropes develops orthostatic hypotension, the answer is dose reduction, not drug addition.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.